مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 M pro , Revealing Its Biophysical Impact on Structural Stability.

Authors : Bano S; Laboratory for Proteins and Structural Biology, Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India.; Singh J

Subjects: Scopoletin*/Scopoletin*/Scopoletin*/pharmacology ; Scopoletin*/Scopoletin*/Scopoletin*/chemistry ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

Source: Viruses [Viruses] 2025 Mar 12; Vol. 17 (3). Date of Electronic Publication: 2025 Mar 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction.

Authors : Bogoyavlenskiy A; Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan.; Alexyuk P

Subjects: Virus Replication*/Virus Replication*/Virus Replication*/drug effects ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

Source: Viruses [Viruses] 2024 Dec 30; Vol. 17 (1). Date of Electronic Publication: 2024 Dec 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial.

Authors : Meiser P; Ursapharm Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.; Flegel M

Subjects: Nasal Sprays* ; Viral Load*/Viral Load*/Viral Load*/drug effects ; Phthalazines*/Phthalazines*/Phthalazines*/administration & dosage

Source: Viruses [Viruses] 2024 Dec 13; Vol. 16 (12). Date of Electronic Publication: 2024 Dec 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice.

Authors : Mattos M; Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-361, RJ, Brazil.; National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-361, RJ, Brazil.

Subjects: Pyrrolidines* ; Valine*/Valine*/Valine*/analogs & derivatives ; Imidazoles*/Imidazoles*/Imidazoles*/pharmacology

Source: Viruses [Viruses] 2024 Nov 29; Vol. 16 (12). Date of Electronic Publication: 2024 Nov 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters.

Authors : Neary M; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK.; Centre of Excellence in Long-Acting Therapeutics (CELT), University of Liverpool, Liverpool L69 3BX, UK.

Subjects: Amides*/Amides*/Amides*/therapeutic use ; Amides*/Amides*/Amides*/pharmacology ; Amides*/Amides*/Amides*/administration & dosage

Source: Viruses [Viruses] 2024 Nov 27; Vol. 16 (12). Date of Electronic Publication: 2024 Nov 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein-HSPA8 Complex Towards Developing COVID-19 Therapeutic Drugs.

Authors : Navhaya LT; Department of Biochemistry, Microbiology, and Biotechnology, University of Limpopo, Turfloop Campus, Sovenga 7270, South Africa.; Matsebatlela TM

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/metabolism ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/chemistry ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/antagonists & inhibitors

Source: Viruses [Viruses] 2024 Oct 31; Vol. 16 (11). Date of Electronic Publication: 2024 Oct 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study.

Authors : Zafilaza K; Laboratoire de Virologie, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Assitance Publique-Hôpitaux de Paris, 75013 Paris, France.; Bellet J

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics SARS-CoV-2 variants

Source: Viruses [Viruses] 2024 Sep 29; Vol. 16 (10). Date of Electronic Publication: 2024 Sep 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments.

Authors : Novitsky V; Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.; Beckwith CG

Subjects: Alanine*/Alanine*/Alanine*/analogs & derivatives ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

Source: Viruses [Viruses] 2024 Sep 24; Vol. 16 (10). Date of Electronic Publication: 2024 Sep 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of the Effect of Early-Onset Steroid Treatment in the COVID-19-Positive Pregnant Women on Pregnancy Outcomes.

Authors : Elgormus N; Department of Microbiology, Faculty of Medicine, Istanbul Atlas University, Istanbul 34008, Turkey.; Senyigit A

Subjects: COVID-19*/COVID-19*/COVID-19*/mortality ; COVID-19*/COVID-19*/COVID-19*/complications ; Pregnancy Complications, Infectious*/Pregnancy Complications, Infectious*/Pregnancy Complications, Infectious*/drug therapy

Source: Viruses [Viruses] 2024 Sep 12; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies.

Authors : Lalle E; Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, 00149 Rome, Italy.; Mazzotta V

Subjects: Saliva*/Saliva*/Saliva*/virology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

Source: Viruses [Viruses] 2024 Jun 27; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 27.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Biochemical Screening of Phytochemicals and Identification of Scopoletin as a Potential Inhibitor of SARS-CoV-2 M pro , Revealing Its Biophysical Impact on Structural Stability.

The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction.

Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial.

Newly Proposed Dose of Daclatasvir to Prevent Lethal SARS-CoV-2 Infection in Human Transgenic ACE-2 Mice.

Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters.

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein-HSPA8 Complex Towards Developing COVID-19 Therapeutic Drugs.

Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study.

Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments.

Evaluation of the Effect of Early-Onset Steroid Treatment in the COVID-19-Positive Pregnant Women on Pregnancy Outcomes.

Saliva Is a Sensitive and Accessible Sample Both for SARS-CoV-2 Detection and for the Evaluation of Treatment Effectiveness in Follow-Up Studies.

اتصل بنا

اتبع